CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (9) ; 179-181 ; DOI: 10.12208/j.ijcr.20240385.

Observation of the effect of early warning score in the treatment of childhood dwarfism with growth hormone
生长激素治疗小儿矮小症中应用儿童早期预警评分的效果观察

作者: 张立 *

灌南县第一人民医院 江苏灌南

*通讯作者: 张立,单位:灌南县第一人民医院 江苏灌南;

发布时间: 2024-09-28 总浏览量: 88

摘要

目的 明确生长激素治疗小儿矮小症中应用儿童早期预警评分的效果。方法 研究纳入2023.02-2024.02中综合临床各项检查结果满足小儿矮小症诊断标准的68例患者,对各个患者进行随机编号后采取随机抽取法安排为两组,对照组与观察组分别35、33例患者,对照组行常规干预,观察组行儿童早期预警评分干预,对不同干预效果进行比较分析。结果 干预后观察组总不良事件例数占比更少,P值结果<0.05,统计学差异大。干预后观察组临床指标各数据值更高,P值结果<0.05,统计学差异大。结论 于小儿矮小症患者接受生长激素治疗中应用儿童早期预警评分,有利于减少不良事件风险,改善临床指标。

关键词: 小儿矮小症;生长激素;儿童早期预警评分

Abstract

Objective: To clarify the effect of using early warning scores in the treatment of pediatric dwarfism with growth hormone. Method: A total of 68 patients who met the diagnostic criteria for pediatric dwarfism based on comprehensive clinical examination results from February 2023 to February 2024 were included in the study. After random numbering, each patient was randomly assigned to two groups: a control group with 35 patients and an observation group with 33 patients. The control group received routine intervention, while the observation group received early childhood warning score intervention. The effects of different interventions were compared and analyzed. After the intervention, the proportion of total adverse events in the observation group was lower, with a P-value of<0.05, indicating a significant statistical difference. After intervention, the clinical indicators in the observation group had higher values, with P values<0.05, indicating a significant statistical difference.
Conclusion  : The application of early childhood warning scores in growth hormone therapy for children with dwarfism is beneficial in reducing the risk of adverse events and improving clinical indicators.

Key words: Pediatric dwarfism; Growth hormone; Early Warning Score for Children

参考文献 References

[1] 张海姣,兰丽珍. 重组人生长激素治疗矮小症的临床效果及治疗期间胰岛素样生长因子、血清碱性磷酸酶的变化[J]. 临床内科杂志,2024,41(7):493-495. 

[2] 王克成,唐海俊,沈莉. 不同病因矮小症患儿血清生长激素释放肽、胰岛素样生长因子-1水平变化及其临床意义[J]. 发育医学电子杂志,2024,12(3):179-186. 

[3] 张德会,程文旭,张伦敏,等. 长效与短效重组人生长激素治疗特发性矮小症患儿的临床研究[J]. 中国临床药理学杂志,2024,40(15):2178-2181. 

[4] 潘凤仙. 儿童早期预警评分在儿科住院患儿病情评估中的应用[J]. 养生保健指南,2021,9(20):141.  

[5] 于庆坤,常丽娜,刘娇娇. 基于儿童早期预警评分的分级护理对发热性惊厥患儿的影响[J]. 中外医学研究,2024,22(17):94-98.   

[6] 刘秋娥,池文欢,王春华. 儿童早期预警评分在儿科病区的应用研究[J]. 江苏卫生事业管理,2021,32(3):316-318,323. 

[7] 刘新俊,邢延霞,张海军. 儿童早期预警评分在小儿重症肺炎病情评估中的应用[J]. 妇儿健康导刊,2024,3(6):49-51,58.

[8] 方功鑫. 儿童早期预警评分在生长激素治疗 小儿矮小症中的应用及对不良反应分析[J]. 大健康,2022,14(10): 163-165.

[9] 李春,岳彩虹. 儿童早期预警评分在矮小症患儿中的应用效果[J]. 中国民康医学,2021,33(10):93-94,97.

引用本文

张立, 生长激素治疗小儿矮小症中应用儿童早期预警评分的效果观察[J]. 国际临床研究杂志, 2024; 8: (9) : 179-181.